Chernett Jorey: insider trades.
Chernett Jorey reported 5 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 5 open-market purchases ($368K) and 0 sales, across 2 companies.
- Transactions
- 5
- Purchases (P)
- 5
- Sales (S)
- 0
- Companies
- 2
- Name as filed
- Chernett Jorey
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Starling Oncology, Inc. (STLN) | TenPercentOwner | 3 |
| Neuronetics, Inc. (STIM) | TenPercentOwner | 2 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-14 | Starling Oncology, Inc. | P | 12,000 | $6.54 | 10,660,858 | Form 4 |
| 2026-08-14 | Neuronetics, Inc. | P | 14,000 | $3.16 | 10,602,988 | Form 4 |
| 2026-07-21 | Oncology Institute, Inc. | P | 18,000 | $5.27 | 10,648,858 | Form 4 |
| 2026-07-14 | Neuronetics, Inc. | P | 35,000 | $1.78 | 10,588,988 | Form 4 |
| 2026-07-10 | Oncology Institute, Inc. | P | 15,000 | $5.85 | 10,630,858 | Form 4 |
Questions
What stock did Chernett Jorey buy or sell?
Chernett Jorey reported 5 non-derivative transactions on 5 SEC ownership filings in Q3 2026: 5 open-market purchases ($368K) and 0 sales, across 2 companies.
Is Chernett Jorey the same person as other filers with this name?
This page covers SEC CIK 2042077 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/chernett-jorey-2042077.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.